← Study Library
Animal · 2014
Preclinicalcounts toward this tierIn vivo growth suppression of CT-26 mouse colorectal cancer cells by adenovirus-expressed small hairpin RNA specifically targeting thymosin beta-4 mRNA
Chao TC, Chan LC, Ju SY, Tang MC, Liu CY, Chen PM, Tzeng CH, Su Y · Cancer Gene Therapy
Preclinicalcounts toward this tier
Silencing Tβ4 induced apoptosis in culture and arrested tumour growth in vivo, which is why the oncology field treats Tβ4 as a target to block. The therapeutic direction in cancer is the opposite of the one gray-market use assumes.
- Population
- Nude mice bearing CT-26 mouse colorectal tumours
- Intervention
- Intratumoral adenovirus expressing shRNA against Tβ4
- Comparator
- Control virus
- Limitations
- Xenograft model in immunodeficient mice; knockdown inside tumour cells, not systemic depletion.
Cited by
1 entry references this study
- TB-500 / thymosin beta-4PRECL.
Peptides → Preclinical & experimental